CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: May 10, 2011
Result type: Reports
Project Number: S0228
Product Line: Common Drug Review

Generic Name: Fingolimod

Brand Name: Gilenya

Manufacturer: Novartis Pharmaceuticals Canada Inc.

Indications: Multiple Sclerosis

Submission Type: New

Project Status: Complete

Date Recommendation Issued: November 16, 2011

Recommendation Type: List with clinical criteria and/or conditions